Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Biolase Inc’s stock clocked out at $0.14, down -6.40% from its previous closing price of $0.15. In other words, the price has decreased by -$6.40 from its previous closing price. On the day, 1.35 million shares were traded. BIOL stock price reached its highest trading level at $0.145 during the session, while it also had its lowest trading level at $0.1255.
Ratios:
To gain a deeper understanding of BIOL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.68 and its Current Ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, The Benchmark Company on June 19, 2019, initiated with a Speculative Buy rating and assigned the stock a target price of $2.
On April 25, 2017, Singular Research started tracking the stock assigning a Buy rating and target price of $2.50.
WallachBeth Downgraded its Buy to Hold on May 13, 2014, whereas the target price for the stock was revised from $4 to $2.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIOL now has a Market Capitalization of 4622709 and an Enterprise Value of 15864640. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.09. Its current Enterprise Value per Revenue stands at 0.323 whereas that against EBITDA is -1.138.
Stock Price History:
Over the past 52 weeks, BIOL has reached a high of $47.10, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is -20.58%, while the 200-Day Moving Average is calculated to be -93.79%.
Shares Statistics:
It appears that BIOL traded 5.62M shares on average per day over the past three months and 1465360 shares per day over the past ten days. A total of 32.52M shares are outstanding, with a floating share count of 31.21M. Insiders hold about 4.05% of the company’s shares, while institutions hold 4.58% stake in the company. Shares short for BIOL as of 1711584000 were 2294681 with a Short Ratio of 0.41, compared to 1709164800 on 245561. Therefore, it implies a Short% of Shares Outstanding of 2294681 and a Short% of Float of 7.06.
Earnings Estimates
The dynamic stock of Biolase Inc (BIOL) is currently attracting attention from ProShares Ultra Bloomberg Natur analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.34, with high estimates of $59.61 and low estimates of $279.73.
